By Nono Hu, Marketing/PR Manager, LSN
BOSTON, Mass. (June 12, 2014) - Dennis Ford, founder and CEO of Life Science Nation, reveals in his new book released today, The Life Science Executive's Fundraising Manifesto, the skill sets required to seek capital in the biotech and medtech arenas...
 | | Click to view the book video |
|
|
LSN continually stresses the importance of producing quality marketing materials. Every client is advised of best practices for investor outreach. A poor presentation can hinder even the most disruptive technology from gaining traction with investors.
Recently, an investor responded to a client's introductory email by saying it was the best he had ever received. So here we dissect that introductory email, using generic details rather than any identifying information.
Our client's first step was to explain who he was, that he was aware of the investor's criteria, and why he believes that his company is a good fit...
|
By Michael Quigley, Research Manager, LSN
The formation of direct-investment arms financed by insurance companies, hospitals, and healthcare providers is a growing trend in the life sciences industry. The research team at LSN has identified at least 15 that are actively seeking opportunities at this time. And after reviewing the 10 most recent investment mandates for these organizations and speaking with them, it is clear that they all have a singular focus: reducing the cost of care. This makes sense. By investing in life science companies, these organizations can lower the costs of care and increase profitability, while establishing an equity position in a growing company. It's a win-win approach... READ MORE |
Life Science Investor Mandates
